Oppenheimer Asset Management Inc. Zai Lab LTD Transaction History
Oppenheimer Asset Management Inc.
- $8.4 Billion
- Q2 2025
A detailed history of Oppenheimer Asset Management Inc. transactions in Zai Lab LTD stock. As of the latest transaction made, Oppenheimer Asset Management Inc. holds 21,974 shares of ZLAB stock, worth $560,776. This represents 0.01% of its overall portfolio holdings.
Number of Shares
21,974
Previous 16,689
31.67%
Holding current value
$560,776
Previous $603,000
27.36%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ZLAB
# of Institutions
171Shares Held
38MCall Options Held
150KPut Options Held
201K-
Capital World Investors Los Angeles, CA6.04MShares$154 Million0.03% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$141 Million2.97% of portfolio
-
Clearbridge Investments, LLC New York, NY4.01MShares$102 Million0.12% of portfolio
-
Janus Henderson Group PLC London, X02.2MShares$56.1 Million0.04% of portfolio
-
Bamco Inc New York, NY1.59MShares$40.5 Million0.16% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.5B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...